Atlas Trials

A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide

Clinical trial NCT04228354 · COMPLETED

Trial details

NCT number
NCT04228354
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteersOverweightObesity
Start date
2020-01-29
Primary completion
2020-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.